Bio


RItish is a 4th year Bioengineering PhD student specializing in cancer biomarker discovery for early detection, therapy monitoring, and therapy selection. He has experience in biopharma drug asset search, scientific evaluation and transaction structuring with Merck's Business Development & Licensing group and expertise in the biopharma, medical device, diagnostics and tools investment and exit landscape with Silicon Valley Bank. In addition to his research, he is working with a dedicated team to improve cervical cancer screening worldwide with his social venture, Luso Labs.

Education & Certifications


  • PhD, Stanford University, Bioengineering
  • M.S., Stanford University, Management Science and Engineering (2018)
  • B.S., Columbia University, Biomedical Engineering (2016)

Stanford Advisors


  • Shan Wang, Doctoral Dissertation Advisor (AC)